12 results
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A
2017 ACC/AHA/HFSA ... for the Management ... #CHF #guideline ... #ACCAHA2017 #cardiology ... treatment #algorithm #sCHF
Heart Failure with Reduced Ejection Fraction (HFrEF) - Guideline Directed Medical Therapy
 • Beta-blocker
 • ACE,
Beta-blocker • ACE ... Heart #Failure #CHF ... #HFrEF #Guideline ... #management #GDMT ... #cardiology
Pharmacology of diuretics

Acetazolamide, Loop diuretics, Thiazide‐like diuretics, MRA, Amiloride

Site of Action, Maximum Dose, Half-Life, Onset, Bioavailability,
Pharmacology of ... #Diuretics #Pharmacology ... #Comparison #Table ... Loop #Thiazide #CHF ... #Cardiology #Management
Heart Failure with Reduced Ejection Fraction (HFrEF) - Guideline Directed Medical Therapy - Initiation Strategies

 •
Stepwise Approach: ACE ... Heart #Failure #CHF ... #HFrEF #Guideline ... #management #GDMT ... #cardiology #titration
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
/ambcarerx #CHF ... #sCHF #HeartFailure ... #HFrEF #Pharmacology ... #Management #Treatment ... #StageC #Cardiology
Iron Deficiency in Heart Failure - Diagnosis and Treatment Algorithm
Diagnosis: Ferritin <100 ng/mL (absolute ID) OR
functional ID) Guidelines ... : • ACC/AHA 2017 ... iron #deficiency #CHF ... heartfailure #diagnosis #management ... #algorithm #cardiology
Heart failure with Reduced Ejection Fraction (HFrEF)
Clinical Presentation
1. Typical symptoms: dyspnea, orthopnea paroxysmal noctumal dyspnea, fatigue,
endomyocardial biopsy Pharmacology ... : • ACE Inhibitors ... heartfailure #diagnosis #management ... #cardiology #pharmacology ... #sCHF
Severe Heart Failure & Cardiogenic Shock - Management Checklist 
Evaluation 
 - EKG & echocardiography
Cardiogenic Shock - Management ... Checklist Evaluation ... #CHF #Shock #Cardiogenic ... #HeartFailure #Cardiology ... #Management
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
metabolic equivalent able ... disease b) CHF ... Stable patients ... one post op Cardiology ... medical and surgical management
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
May have typical HF ... • Avoid ARB/ACE-I ... Delivery • Stable ... e.g., <50%), ESC guidelines ... #cardiology #treatment